Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis: A single center's experience over one decade

Peritoneal Dialysis International

Volumn 24, Issue 5, 2004, Pages 424-432

  Kim, Dong Ki ^a   Yoo, Tae Hyun ^a   Ryu, Dong Ryeol ^a   Xu, Zhong Gao ^a   Kim, Hyun Jin ^a   Choi, Kyu Hun ^a   Lee, Ho Yung ^a   Han, Dae Suk ^a,b   Kang, Shin Wook ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

Antimicrobial susceptibility; Coagulase negative staphylococcus; Gram negative organism; Gram positive organism; Peritonitis; Staphylococcus aureus

Indexed keywords

AMIKACIN; AMPICILLIN; CEFAZOLIN; GENTAMICIN; IMIPENEM; METICILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN; VANCOMYCIN;

ADULT; ANTIBIOTIC SENSITIVITY; BACTERIAL PERITONITIS; CLINICAL PROTOCOL; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEALTH CARE FACILITY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROORGANISM; MORTALITY; PERITONEAL CATHETER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; STAPHYLOCOCCUS AUREUS; STATISTICAL SIGNIFICANCE;

EID: 7444235485     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080402400506     Document Type: Review

References (41)

1. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol 1996; 7:198-207.
2. Davies SJ, Phillips L, Griffiths AM, Russell LH, Naish PF, Russell GI. What really happens to people on long-term peritoneal dialysis? Kidney Int 1998; 54:2207-17.
3. Piraino B. Peritonitis as a complication of peritoneal dialysis. J Am Soc Nephrol 1998; 9:1956-64.
4. Gokal R. Peritoneal dialysis in the 21st century: an analysis of current problems and future developments. J Am Soc Nephrol 2002; 13(Suppl 1):S104-16.
5. Lee GS, Woo KT. Infection in continuous ambulatory peritoneal dialysis (CAPD): aetiology, complications and risk factors. Ann Acad Med Singapore 1992; 21: 354-60.
6. Burkart JM, Hylander B, Durnell-Figel T, Roberts D. Comparison of peritonitis rates during long-term use of standard spike versus Ultraset in continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 1990; 10:41-3.
7. Port FK, Held PJ, Nolph KD, Turenne MN, Wolfe RA. Risk of peritonitis and technique failure by CAPD connection technique: a national study. Kidney Int 1992; 42:967-74.
8. Tielens E, Nube MJ, de Vet JA, van Limbeek J, Hofman X, Steffens A, et al. Major reduction of CAPD peritonitis after the introduction of the twin-bag system. Nephrol Dial Transplant 1993; 8:1237-43.
9. Kiernan L, Kliger A, Gorban-Brennan N, Juergensen P, Tesin D, Vonesh E, et al. Comparison of continuous ambulatory peritoneal dialysis-related infections with different "Y-tubing" exchange systems. J Am Soc Nephrol 1995; 5:1835-8.
10. Daly CD, Campbell MK, MacLeod AM, Cody DJ, Vale LD, Grant AM, et al. Do the Y-set and double-bag systems reduce the incidence of CAPD peritonitis? A systematic review of randomized controlled trials. Nephrol Dial Transplant 2001; 16:341-7.
11. Bernardini J, Holley JL, Johnston JR, Perlmutter JA, Piraino B. An analysis of ten-year trends in infections in adults on continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol 1991; 36:29-34.
12. Bunke CM, Brier ME, Golper TA. Outcomes of single organism peritonitis in peritoneal dialysis: gram negatives versus gram positives in the Network 9 peritonitis study. Kidney Int 1997; 52:524-9.
13. Zelenitsky S, Barns L, Findlay I, Alfa M, Ariano R, Fine A, et al. Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998. Am J Kidney Dis 2000; 36:1009-13.
14. Fried LF, Bernardini J, Johnston JR, Piraino B. Peritonitis influences mortality in peritoneal dialysis patients. J Am Soc Nephrol 1996; 7:2176-82.
15. Kiernan L, Finkelstein FO, Kliger AS, Gorban-Brennan N, Juergensen P, Mooraki A, et al. Outcome of polymicrobial peritonitis in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 1995; 25:461-4.
16. Troidle L, Gorban-Brennan N, Kliger A, Finkelstein F. Differing outcomes of gram-positive and gram-negative peritonitis. Am J Kidney Dis 1998; 32:623-8.
17. Krishnan M, Thodis E, Ikonomopoulos D, Vidgen E, Chu M, Bargman JM, et al. Predictors of outcome following bacterial peritonitis in peritoneal dialysis. Perit Dial Int 2002; 22:573-81.
18. Keane WF, Bailie GR, Boeschoten E, Gokal R, Golper TA, Holmes CJ, et al. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update [Published erratum appears in Perit Dial Int 2000; 20: 828-9]. Perit Dial Int 2000; 20:396-411.
19. Keane WF, Everett ED, Golper TA, Gokal R, Halstenson C, Kawaguchi Y, et al. Peritoneal dialysis-related peritonitis treatment recommendations: 1993 update. The Ad Hoc Advisory Committee on Peritonitis Management. International Society for Peritoneal Dialysis. Perit Dial Int 1993; 13:14-28.
20. Corey P. An approach to the statistical analysis of peritonitis data from patients on CAPD. Perit Dial Bull 1981; 1:(Suppl 1):S29-32.
21. Farias MG, Soucie MJ, McClellan W, Mitch WE. Race and the risk of peritonitis: an analysis of factors associated with the initial episode. Kidney Int 1994; 46: 1392-6.
22. Fine A, Cox D, Bouw M. Higher incidence of peritonitis in native Canadians on continuous ambulatory peritoneal dialysis. Perit Dial Int 1994; 14:227-30.
23. Korbet SM, Vonesh EF, Firanek CA. Peritonitis in an urban peritoneal dialysis program: an analysis of infecting pathogens. Am J Kidney Dis 1995; 26:47-53.
24. Tranaeus A, Heimburger O, Lindholm B. Peritonitis during continuous ambulatory peritoneal dialysis (CAPD): risk factors, clinical severity, and pathogenetic aspects. Perit Dial Int 1988; 8:253-63.
25. De Vecchi AF, Maccario M, Braga M, Scalamogna A, Castelnovo C, Ponticelli C. Peritoneal dialysis in non-diabetic patients older than 70 years: comparison with patients aged 40 to 60 years. Am J Kidney Dis 1998; 31:479-90.
26. Rodriguez-Carmona A, Perez FM, Garcia FT, Fernandez RC, Valdes F. A comparative analysis on the incidence of peritonitis and exit-site infection in CAPD and automated peritoneal dialysis. Perit Dial Int 1999; 19: 253-8.
27. Sprosen TS, Miserque D, Story KO, Divino Filho JC. Significant reduction in peritonitis observed in patients prescribed the biocompatible PD solution Physioneal: first data from the European PD Solutions Registry [Abstract]. Perit Dial Int 2002; 22:148.
28. Van Biesen W, Vanholder R, Vogelaers D, Peleman R, Verschraegen G, Vijt D, et al. The need for a center-tailored treatment protocol for peritonitis. Perit Dial Int 1998; 18:274-81.
29. Piraino B. Peritoneal infections. Adv Ren Replace Ther 2000; 7:280-8.
30. Millikin SP, Matzke GR, Keane WF. Antimicrobial treatment of peritonitis associated with continuous ambulatory peritoneal dialysis. Perit Dial Int 1991; 11: 252-60.
31. Vas S, Bargman J, Oreopoulos D. Treatment in PD patients of peritonitis caused by gram-positive organisms with single daily dose of antibiotics. Perit Dial Int 1997; 17:91-4.
32. Agraharkar M, Klevjer-Anderson P, Rubinstien E, Galen M. Use of cefazolin for peritonitis treatment in peritoneal dialysis patients. Am J Nephrol 1999; 19: 555-8.
33. Lyytikainen O, Vaara M, Jarviluoma E, Rosenqvist K, Tiittanen L, Valtonen V. Increased resistance among Staphylococcus epidermidis isolates in a large teaching hospital over a 12-year period. Eur J Clin Microbiol Infect Dis 1996; 15:133-8.
34. Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. Mupirocin Study Group. J Am Soc Nephrol 1996; 7:2403-8.
35. Bernardini J, Piraino B, Holley J, Johnston JR, Lutes R. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin. Am J Kidney Dis 1996; 27:695-700.
36. Thodis E, Passadakis P, Vargemezis V, Oreopoulos DG. Prevention of catheter related infections in patients on CAPD. Int J Artif Organs 2001; 24:671-82.
37. Keane WF, Vas S. Peritonitis. In: Gokal R, Nolph KD, eds. The Textbook of Peritoneal Dialysis. Dordrecht: Kluwer Academic; 1994: 473-501.
38. Krothapalli R, Duffy WB, Lacke C, Payne W, Patel H, Perez V, et al. Pseudomonas peritonitis and continuous ambulatory peritoneal dialysis. Arch Intern Med 1982; 142:1862-3.
39. Bernardini J, Piraino B, Sorkin M. Analysis of continuous ambulatory peritoneal dialysis-related Pseudomonas aeruginosa infections. Am J Med 1987; 83:829-32.
40. Juergensen PH, Finkelstein FO, Brennan R, Santacroce S, Ahern MJ. Pseudomonas peritonitis associated with continuous ambulatory peritoneal dialysis: a six-year study. Am J Kidney Dis 1988; 11:413-17.
41. Taber TE, Hegeman TF, York SM, Kinney RA, Webb DH. Treatment of Pseudomonas infections in peritoneal dialysis patients. Perit Dial Int 1991; 11:213-16.